Home » Topics » Regulatory

Regulatory
RSS

FDA approves Imlygic as first oncolytic viral therapy in U.S.

Oct. 28, 2015

FDA approves Belbuca buccal film for chronic pain

Oct. 28, 2015

FDA approves Yondelis for liposarcoma and leiomyosarcoma

Oct. 26, 2015

FDA approves Merrimack's liposomal irinotecan for pancreatic cancer

Oct. 23, 2015

FDA approves Veltassa for hyperkalemia

Oct. 22, 2015

FDA approves Coagadex for hereditary factor X deficiency

Oct. 21, 2015

FDA approves Praxbind as dabigatran reversal agent

Oct. 19, 2015

FDA approves Aristada for schizophrenia

Oct. 6, 2015

Maruho's Zebiax approved in Japan for bacterial skin infections

Sep. 30, 2015

Shionogi's Mulpleta approved in Japan for thrombocytopenia

Sep. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...